Department of Pharmacology and Toxicology
University of Bonn
Sigmund-Freud-Straße 25 - 53127 Bonn - Germany




 Picture PD Dr. M. Kathmann - More...
[Curriculum Vitae] [Selected Publications] [Further Publications] [Poster]

 

Schlicker E, Kathmann M (2008) Presynaptic neuropeptide receptors. Handb Exp Pharmacol 184:409-34
Abstract Schlicker & Kathmann (2008)  
Schultheiss T, Flau K, Kathmann M, Göthert M, Schlicker E (2005) Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta. Naunyn Schmiedebergs Arch Pharmacol 372:139-146
Abstract Schultheiss et al. (2004)  
Stark H, Kathmann M, Schlicker E, Schunack W, Schlegel B, Sippl W (2004) Medicinal Chemical and Pharmacological Aspects of Imidazole-Containing Histamine H3 Receptor Antagonists. Mini-Reviews in Medicinal Chemistry 4:965-977
Abstract Stark et al. (2004)  
Schlicker E, Redmer A, Werner A, Kathmann M (2003) Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release. Br J Pharmacol 140:323-328
Abstract Schlicker et al. (2003)  
Malinowska B, Kiec-Kononowicz K, Flau K, Godlewski G, Kozlowska H, Kathmann M, Schlicker E (2003) Atypical cardiostimulant b-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues. Br J Pharmacol 139:1548-1554
Abstract Malinowska et al. (2003)  
Redmer A, Kathmann M, Schlicker E (2003) Cannabinoid CB1 receptor-mediated inhibition of hippocampal acetylcholine release is preserved in aged mice. Br J Pharmacol 138:1425-1430
Abstract Redmer et al. (2003)  
Liedtke S, Flau K, Kathmann M, Schlicker E, Stark H, Meier G, Schunack W (2003) Replacement of imidazole by a piperidine moiety differentially affects the potency of histamine H3-receptor antagonists. Naunyn-Schmiedebergs Arch Pharmacol 367:43-50
Abstract Liedtke et al. (2003)  
Flau K, Redmer A, Liedtke S, Kathmann M, Schlicker E (2002) Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors. Br J Pharmacol 137:1355-1361
Abstract Flau et al. (2002)  
Nickel T, Bauer U, Schlicker E, Kathmann M, Göthert M, Sasse A, Stark H, Schunack W (2001) Novel histamine H3-receptor antagonists and partial agonists with a nonaminergic structure. Br J Pharmacol 132:1665-1672
Abstract Nickel et al. (2001)  
Drutel G, Kathmann M, Heron A, Gros C, Mace S, Schwartz JC, Arrang JM (2000) Two splice variants of the hypoxia-inducible factor HIF-1alpha as potential dimerization partners of ARNT2 in neurons. Eur J Neurosci 12:3701-3708
Abstract Drutel et al. (2000)  
Molderings GJ, Menzel S, Kathmann M, Schlicker E, Göthert M (2000) Dual interaction of agmatine with the rat a2D-adrenoceptors: competitive antagonism and allosteric activation. Br J Pharmacol 130:1706-1712
Abstract Molderings et al. (2000)  
Nakazi M, Bauer U, Nickel T, Kathmann M, Schlicker E (2000) Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 361:19-24
Abstract Nakazi et al. (2000)  
Drutel G, Heron A, Kathmann M, Gros C, Mace S, Plotkine M, Schwartz JC, Arrang JM (1999) ARNT2, a transcription factor for brain neuron survival? Eur J Neurosci 11:1545-1553
Abstrakt Drutel et al. (1999)  
Werthwein S, Bauer U, Nakazi M, Kathmann M, Schlicker E (1999) Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro Br J Pharmacol 127:300-308
Abstract Werthwein et al. (1999)  
Bauer U, Nakazi M, Kathmann M, Göthert M, Schlicker E (1999) The stereoselective k opioid receptor antagonist Mr 2266 does not exhibit stereoselectivity as an antagonist at the orphan opiod (ORL1) receptor. Naunyn-Schmiedeberg's Arch Pharmacol 359:17-20
Abstract Bauer et al. (1999)  
Kathmann M, Schlicker E, Marr I, Werthwein S, Stark H, Schunack W (1998) Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists. Naunyn-Schmiedeberg's Arch Pharmacol 358:623-627
Abstract Kathmann et al. (1998)  
Schlicker E, Werthwein S, Kathmann M, Bauer U (1998) Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORL1 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 358: 418-422
Abstract Schlicker et al. (1998)  
Schlicker E, Fink K, Kathmann M, Molderings GJ, Göthert M (1997) Effects of imidazolines on noradrenaline release in brain: an investigation into their relationship to imidazoline, alpha2 and H3 receptors. Neurochem Int 30: 73-83
Abstract Schlicker et al. (1997)  
Schlicker E, Kathmann M, Bitschnau H, Marr I, Reidemeister S, Stark H, Schunack W (1996) Potencies of antagonists chemically related to iodoproxyfan at histamine H3 receptors in mouse brain cortex and guinea-pig ileum: evidence for H3 receptor heterogeneity? Naunyn-Schmiedeberg's Arch Pharmacol 353: 482-488
Abstract Schlicker et al. (1996)  
Leurs R, Kathmann M, Vollinga RC, Menge WM, Schlicker E, Timmerman H (1996) Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity? J Pharmacol Exp Ther 276: 1009-1015
Abstract Leurs et al. (1996)  
Schlicker E, Pertz H, Bitschnau H, Purand K, Kathmann M, Elz S, Schunack W (1995) Effects of iodoproxyfan, a potent and selective histamine H3 receptor antagonist, on alpha2 and 5-HT3 receptors. Inflamm Res 44: 296-300
Abstract Schlicker et al. (1995)  
Schlicker E, Kathmann M, Reidemeister S, Stark H, Schunack W (1994) Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models. Br J Pharmacol 112: 1043-1048
Abstract Schlicker et al. (1994)  
Schlicker E, Kathmann M, Detzner M, Exner HJ, Göthert M (1994) H3 receptor-mediated inhibition of noradrenaline release: an investigation into the involvement of Ca2+ and K+ ions, G protein and adenylate cyclase. Naunyn-Schmiedeberg's Arch Pharmacol 350: 34-41
Abstract Schlicker et al. (1994)  
Detzner M, Kathmann M, Schlicker E (1994) Time course of the effects of histamine, thioperamide and EEDQ on H3 receptors in the mouse brain. Agents Actions 41 Spec No: C66-C67
Abstract Detzner et al. (1994)  
Schlicker E, Malinowska B, Kathmann M, Göthert M (1994) Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam Clin Pharmacol 8: 128-137
Abstract Schlicker et al. (1994)  
Schlicker E, Kathmann M, Exner HJ, Detzner M, Göthert M (1994) The 5-HT3 receptor agonist 1-(m-chlorophenyl) -biguanide facilitates noradrenaline release by blockade of alpha2-adrenoceptors in the mouse brain cortex. Naunyn-Schmiedeberg's Arch Pharmacol 349: 20-24
Abstract Schlicker et al. (1994)  
Kathmann M, Schlicker E, Detzner M, Timmerman H (1993) Nordimaprit, homodimaprit, clobenpropit and imetit: affinities for H3 binding sites and potencies in a functional H3 receptor model. Naunyn-Schmiedeberg's Arch Pharmacol 348: 498-503
Abstract Kathmann et al. (1993)  
Schlicker E, Malinowska B, Kathmann M (1993) CGP 35348 blocks noradrenaline-release-inhibiting GABAB receptors in the pig retina, rat vena cava and pithed rat vasculature. Pharmacology 47: 111-116
Abstract Schlicker et al. (1993)  


German Version

up

[Start] [Research] [Homepage] [Publications] [Poster] [Download] [Curriculum Vitae] [Links] [Impressum]

© Kathmann, last modified 11.01.2012

Print this page